# Prognosis and Therapeutic Biomarkers for Glioblastoma Patients

> **NCT03403803** · — · TERMINATED · sponsor: **Baylor Research Institute** · enrollment: 10 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DEVICE:** Optune

## Key facts

- **NCT ID:** NCT03403803
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-01
- **Primary completion:** 2019-03-25
- **Final completion:** 2019-03-25
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Were not able to meet enrollment goal due to inclusion/exclusion criteria
- **Last updated:** 2019-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03403803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03403803, "Prognosis and Therapeutic Biomarkers for Glioblastoma Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03403803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*